Barclays raises S&P 500 target, Amgen stock slumps after trial failure, and oil prices rise due to escalating Middle East hostilities.
1 report, 1 independent
Updated Sep 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Barclays raises S&P 500 target, Amgen stock slumps after trial failure, and oil prices rise due to escalating Middle East hostilities.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Barclays
British bank
-
Amgen
American multinational biopharmaceutical company
-
Middle East
geopolitical region encompassing Egypt and most of Western Asia, including Iran